Ads
related to: AstraZeneca- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Lab Products & Equipment
Shop our huge portfolio of labware
equipment from leading brands.
- Sigma® Life Science
Cell culture, antibodies
and more biological products
- Order Center
Build a Shopping Cart, View Orders
Access ordering instructions
- Analytical/Chromatography
Browse our Analytical Reagents,
Standards, Microbiology and more.
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Sign In
Search results
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Benzinga via Yahoo Finance· 21 hours agoThursday, AstraZeneca Plc (NASDAQ:AZN) reported first-quarter sales of $12.68 billion, up 17% year...
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 19 hours agoImage source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q1 2024 Earnings Call Apr 25, 2024,...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance via AOL· 16 hours agoAstraZeneca's (AZN) stock is up following its latest earnings report Thursday after the company...
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 22 hours agoWhile the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business...
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Investor's Business Daily· 16 hours agoAstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after...
Cancer drugs help drive AstraZeneca sales sharply higher
PA Media: Money via Yahoo Finance· 23 hours agoAstraZeneca revealed soaring sales over the latest quarter as it was boosted by its cancer drugs....
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 18 hours agoAstraZeneca’s AZN first-quarter 2024 core earnings of $1.03 per American depositary share (ADS) beat...
AstraZeneca Earnings, Sales Rise, Beat Forecasts
The Wall Street Journal· 1 day agoHEALTH AstraZeneca posted increased first-quarter core earnings per share and sales that beat forecasts. The Anglo-Swedish pharmaceutical giant said...
AstraZeneca leaps after smashing first-quarter forecasts
Reuters via Yahoo News· 1 day agoAstraZeneca sailed past market expectations for quarterly revenue and profit on Thursday, boosted by...
What's Driving AstraZeneca PLC's Surprising 14% Stock Rally?
Guru Focus· 17 hours agoAstraZeneca PLC (AZN, Financial) has recently seen a notable uptick in its stock performance, with a market capitalization now standing at a robust $231.04 billion. Over the ...